The Application of Digital Morphology in Haematology Education. Barbara De la Salle Deputy Director UK NEQAS General Haematology
|
|
- Arron Horton
- 6 years ago
- Views:
Transcription
1 The Application of Digital Morphology in Haematology Education Barbara De la Salle Deputy Director UK NEQAS General Haematology
2 8 November, 2011 UK National External Quality Assessment Service comprises a network of 144 schemes operating from 24 centres based at major hospitals, research institutions and universities throughout the UK
3 West Herts Hospitals Trust
4
5 Digital Slides All view the same cell(s) Microscopy vs morphology skills Direct annotation: education/training Relatively low cost Viewable by limitless numbers Easy to store
6 Hutchinson CV et al Clin Lab Haem (2005)
7 Patient Details Age (yrs) Sex Hb(g/l) WBC(x10 9 /l) Platelets (x10 9 /l) 55 f Expert Comment (Dr J Parker-Williams, Scheme Director, UK NEQAS) This film was prepared from a blood specimen taken from a fifty-five-year-old-lady, who was diagnosed with myelofibrosis in This is a film with complex morphological abnormalities - too many to score as many stated! Myelofibrosis was diagnosed in 1992; a splenectomy was performed in 1996 for increasing splenomegaly; twenty percent of participants recorded features of hyposplenism. The majority felt that the features were those of a myeloproliferative/myelodysplastic disorder with transformation to AML-M7. The five most commonly reported features were: Nucleated red cells Blast cells Macrocytic platelets Myelocytes Megakaryocyte fragments.
8 2004 Exercise: stitched images
9 2004: Rate the Exercise With thanks to Michelle Brereton, Manchester Royal Infirmary
10 Feedback 2004: High quality, large scale, stitched slides Easy to use software Educational content Access for more participants
11 Photograph single high power images
12 Take multiple overlapping fields
13 Computer software matches fields
14 While still retaining details that can be viewed at high power
15 2007: UK NEQAS / SlidePath not for profit collaboration UK NEQAS images Digital Slidebox software Secure, on-line, individual participation
16
17 Digital Morphology CPD Scheme Launched April 2008 Individual participation Educational in purpose 6 cases per year 2000 individual licenses returns per case Laboratory manager admin pages 2011 Additional educational content for 2012
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34 Feedback from users It is a relatively effortless way for my staff to create evidence of CPD This strengthens the knowledge of all of my staff and improves their validation knowledge It s more personal and removes some of the pressure of similar schemes. It is more comfortable for less experienced staff to participate
35 Cases issued
36 First Case DM1 Previous UK NEQAS 0507BF2 37 year old, female, SE Asia Hepatosplenomegaly, transfused Hb 7.2 g/dl, RBC 4.36, MCV 55, MCH 17 DIAGNOSIS Complex haemoglobinopathy: Hb A + Hb E + Hb Barts Disease
37 Top 5 Features 0801DM1 Glass slide Digital slide 1 Target cells Target cells 2 Hypochromic RBC Punctate basophilia 3 Tear drop poikilocytes Tear drop poikilocytes 4 Punctate basophilia RBC fragments etc 5 Poikilocytes Hypochromic RBC
38 Second Case DM1 Previous UK NEQAS 0505BF1 83 year old, female Transient ischaemic attack, angina, hypertension Hb 11.2 g/dl, WBC 138, Platelets 7 DIAGNOSIS Lymphoproliferative disorder: T-PLL
39 Top 5 Features 0802DM1 Glass slide Digital slide 1 Thrombocytopenia Thrombocytopenia 2 Lymphocytosis Lymphocytosis 3 Smear/smudge cells Smear/smudge cells 4 Prolymphocytes Cleft nuclei 5 Cleft nuclei Neutropenia
40 Questionnaire completed survey Overall feedback was positive with several good suggestions on improvement
41 Participant groups surveyed 2% 14% 2% 11% Laboratory Manager Chief or Senior BMS Specialist BMS 36% Basic grade BMS Generic/ non Specialist BMS. Trainee BMS 35% Other (please specify)
42 Type of organisation 2% 6% 26% Teaching District General Private Other (please specify) 66%
43 Background Haematology 37.7% Haematology/Transfusion 50.5% Blood transfusion 5.5% Combined Blood Sciences 4.5% Others 1.8% Leukaemia diagnosis Stem Cell Laboratory Haemato-Oncology
44 Morphology Experience How much morphology experience do you have? 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% Report under supervision Regularly issue reports Issue reports out of hours Occasionally report films Not currently practising Series1 6.0% 59.3% 13.7% 16.2% 4.7%
45 Quality of DM Process Very good/good (%) Very poor/poor (%) 120 Good/Very Good (%) Poor/Very Poor(%) Range of cases Quality of images Stain quality Case questions Range of cases Quality of images Stain quality Case questions
46 Cases: viewed / completed 30.0% How many cases completed % How many cases viewed % 25.0% 20.0% 15.0% 10.0% 5.0% How many cases completed % 0.0% How many cases viewed % None >7 3.9% 17.6% 23.0% 19.1% 17.9% 18.5% 1.5% 15.7% 20.5% 19.3% 18.4% 24.5%
47 Lab Managers: 87% - Registration is easy 70% - Want on-line management and to track staff participation
48 UK NEQAS Digital Morphology Workshop participants, all DM users 95% rated the educative morphology narrative as useful 76% liked comparison of their results against others 70% felt the programme met their expectations
49 Collaborative Activities British Society for Haematology slide sessions Institute of Biomedical Science slide sessions International Society for Laboratory Haematology morphology workshop 2008 World Health Organisation photo-gallery
50 Conclusions Novel educational programme for laboratory scientists High level of satisfaction with quality and case mix Demonstrated increased confidence amongst participants: % offered a diagnosis % offered a diagnosis
51 Finally.. I have just completed the first module of the scheme and I must say that I have found it very informative and instructive, even for someone with my experience. The website was very clear to navigate around and the quality of the images was excellent. The teaching input was very comprehensive and has proved to be of great benefit and interest to all my staff taking part. Many thanks for what promises to be an innovative and instructive scheme. A participant s comment
52 Acknowledgements Manchester Royal Infirmary, UK Michelle Brereton, John Burthem, John Ardern UK NEQAS General Haematology staff and advisors Zuotimi Eke, John Parker-Williams, Keith Patterson, Paul McTaggart, Mary West, Keith Hyde Manchester Universities, UK Len Seal, Laura Tatum UK NEQAS participants
53
Barbara De la Salle Director, UK NEQAS Haematology
Barbara De la Salle Director, UK NEQAS Haematology UK NEQAS Haematology developments (with apologies to Ian Mellors) UKAS assessors ISO15189 (Laboratories) ISO17043 (Scheme) Oversight bodies (NQAAP) Strategic
More informationUK NEQAS for General Haematology Annual Report January December 2010
UK NEQAS for General Haematology Annual Report January December 00 February 0 Scheme Director: Scheme Manager: Professor Keith Hyde Mrs Barbara De la Salle UK NEQAS (H) PO Box 4 Watford WD8 0FJ United
More informationLaboratory for diagnosis of THALASSEMIA
SCBM343 CLINICAL PATHOLOGY 2(1-2-3) Laboratory for diagnosis of THALASSEMIA PORNTHIP CHAICHOMPOO pornthip.chh@mahidol.ac.th Acknowledgements Dr. Pranee Winichagoon Fucharoen Ms. Pornnapa Khampan Thalassemia
More informationLeukocytosis - Some Learning Points
Leukocytosis - Some Learning Points Koh Liang Piu Department of Hematology-Oncology National University Cancer Institute National University Health System Objectives of this talk: 1. To provide some useful
More informationMYELOPROLIFARATIVE NEOPLASMS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin).
MYELOPROLIFARATIVE NEOPLASMS Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin). These are a group of chronic conditions characterised by clonal proliferation of marrow precursor cells. PRV, essential thrombocyathaemia,
More informationFull Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa
Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa The Role of the FBC in clinical decision making History Examination Investigations Decision 70% FBC Laboratory
More informationMaggie Keswick Jencks Cancer Caring Centres Trust Job Description. In accordance with Maggie s policies and procedures
Maggie Keswick Jencks Cancer Caring Centres Trust Job Description 1. JOB TITLE: Cancer Support Specialist REPORTS TO: PROFESSIONAL SUPERVISION: Centre Head In accordance with Maggie s policies and procedures
More informationPolycthemia Vera (Rubra)
Polycthemia Vera (Rubra) Polycthemia Vera (Rubra) Increased red cells Clonal Myeloid lineages also increased 2-13 cases per million Mean age: 60 years Sites of Involvement Bone marrow Peripheral blood
More informationHEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia
HEFT Pathology Guideline GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia Produced by: Dr Charalampos Kartsios (Consultant Haematologist) and Muhammad Javed
More informationYear 2003 Paper two: Questions supplied by Tricia
QUESTION 65 A 36-year-old man presents in a post-ictal state after an observed generalised seizure. Full blood investigation shows: haemoglobin 0 g/l [128-175] mean corpuscular volume (MCV) 106 fl [80-7]
More informationChronic Idiopathic Myelofibrosis (CIMF)
Chronic Idiopathic Myelofibrosis (CIMF) CIMF Synonyms Agnogenic myeloid metaplasia Myelosclerosis with myeloid metaplasia Chronic granulocytic-megakaryocytic myelosis CIMF Megakaryocytic proliferation
More informationDevelopment of a Blood Transfusion Knowledge Based Competency Assessment Scheme
Development of a Blood Transfusion Knowledge Based Competency Assessment Scheme Clare Milkins Jenny White Bill Chaffe Scheme Manager Deputy Scheme Manager Senior EQA Scientist Why the perceived need? (Mis)-use
More informationMaggie Keswick Jencks Cancer Caring Centres Trust Job Description. 1. JOB TITLE: Cancer support specialist. procedures
Maggie Keswick Jencks Cancer Caring Centres Trust Job Description 1. JOB TITLE: Cancer support specialist REPORTS TO: PROFESSIONAL SUPERVISION: RESPONSIBLE FOR: LIAIASES WITH: Centre Head In accordance
More informationExternal Quality Assurance in Genetics Laboratories
Genetics Quality and Accreditation workshop External Quality Assurance in Genetics Laboratories Farrah Khawaja Deputy Scheme Director UK NEQAS for Molecular Genetics The Royal Infirmary of Edinburgh Molecular
More informationSchool of Improvement Supporting trainees from Students to Consultants
School of Improvement Supporting trainees from Students to Consultants 2018 Prospectus Welcome to the School of Improvement Guy s and St Thomas NHS Foundation Trust is one of the largest teaching hospitals
More informationPerspective on performance: The Haemoglobinopathies. Barbara Wild
Perspective on performance: The Haemoglobinopathies Barbara Wild Perspective on Performance: Performance assessment process DNA diagnostics for Haemoglobinopathies scheme Outcomes of shadow scoring exercise
More informationAbnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust
Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Regional Paediatric Specialty Trainees teaching 4 th July 2017 Scope
More informationMyelodysplastic syndrome (MDS) & Myeloproliferative neoplasms
Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) A multipotent stem cell that can differentiate into any of the myeloid lineage cells (RBCs, granulocytes, megakaryocytes)
More informationContinuing Education Questions
FOCUS: INTERPRETING THE COMPLETE BLOOD COUNT Continuing Education Questions SUMMER 2017 1. A methodical approach to CBC interpretation that is aimed at medical laboratory professionals differs from one
More informationInstitute of Psychiatry, Psychology & Neuroscience
Maudsley International a specialist mentalhealth and wellbeing consultancy Maudsley International is an expert organisation that helps its clients develop and improve services and support for people who
More informationThe audit is managed by the Royal College of Psychiatrists in partnership with:
Background The National Audit of Dementia (NAD) care in general hospitals is commissioned by the Healthcare Quality Improvement Partnership on behalf of NHS England and the Welsh Government, as part of
More informationHaematology dilemma s to refer or not to refer?
Haematology dilemma s to refer or not to refer? NWL Pathology GP Study Day Dr Fatts Chowdhury Consultant Haematologist in Transfusion Medicine NHS Blood and Transplant Senior Honorary Clinical Lecturer
More informationHematopathology Case Study
Hematopathology Case Study AMP Outreach Course 2009 AMP Annual Meeting John Greg Howe Ph.D. Department of Laboratory Medicine Yale University School of Medicine November 19, 2009 HISTORY Case History An
More informationFBC interpretation. Dr. Gergely Varga
FBC interpretation Dr. Gergely Varga #1 71 Y/O female, c/o weakness Test Undertaken : FBC (FBC) Sample Type: Whole Blood [ - 26.09.11 14:59] Hb 7.3 g/dl* 12.0-15.5 RBC 3.5 10^12/l * 3.80-5.60 Hct 0.24
More informationComplete Blood Count in Primary Care
QUIZ FEEDBACK Complete Blood Count in Primary Care bpac nz better medicine GP Review Panel: Dr Janine Bailey, Motueka Dr Susie Lawless, Dunedin Dr Randall Sturm, Auckland Dr Neil Whittaker, Nelson Specialist
More informationSurvey of local governors associations 2014
Survey of local governors associations 2014 Thank you to the 30 local associations that took part in our survey. This represents just under half of the local associations who are in membership of National
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA) Ruxolitinib for the treatment of myelofibrosis
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More informationInterpreting Hematology Scatter-Plots; One Cancer Center s Keys to Seeing the BIG Picture
Interpreting Hematology Scatter-Plots; One Cancer Center s Keys to Seeing the BIG Picture Barbara L. Burch, MHA MT (ASCP) Laboratory Manager New York University Clinical Cancer Center Disclosure Ms Burch
More informationCRITERIA FOR CREDENTIALLING A PAEDIATRIC HAEMATOLOGIST- ONCOLOGIST IN THE MALAYSIAN SPECIALIST REGISTER
Page 10f8 REVISED (29-8-09) CRITERIA FOR CREDENTIALLING A PAEDIATRIC HAEMATOLOGIST- ONCOLOGIST IN THE MALAYSIAN SPECIALIST REGISTER The criteria are as follows: 1. A basic medical degree recognised by
More informationNational Horizon Scanning Centre. Azacitidine (Vidaza) for myelodysplastic syndrome. September 2007
Azacitidine (Vidaza) for myelodysplastic syndrome September 2007 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to
More informationMDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?
101 May 17, 2014 Myelodysplastic Syndrome: Let s build a definition Myelo bone marrow Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine What is bone marrow? What does bone
More informationThe Liverpool Hands On Cardiac Pacing Course
The Liverpool Hands On Cardiac Pacing Course Venue: Hilton Hotel, Liverpool th th 18 & 19 June, 2018 Director Dr Khaled Albouaini, Consultant Cardiologist Royal Liverpool University Hospital & Liverpool
More informationPathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16
35 Pathology #11 Acute Leukemias Farah Banyhany Dr. Sohaib Al- Khatib 23/2/16 1 Salam First of all, this tafreegh is NOT as long as you may think. If you just focus while studying this, everything will
More informationCandidates must answer ALL questions
Time allowed: Three hours. Part 1 examination Haematology: First paper Tuesday 22 March 2016 Candidates must answer ALL questions Question 1: General Haematology A 16 year old non-european is referred
More informationCase Presentation No. 075
Case Presentation No. 075 Session 4. Myelodysplastic Syndrome Cristina Montalvo, MD Baylor College of Medicine Houston, Texas 2007 Workshop of Society for Hematopathology and European Association for Haematopathology
More informationRory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital
Rory McCulloch Specialty Trainee Haematology Royal Devon & Exeter Hospital Anaemia 1 Haematological disorders Anaemia 2 Non-haematological disorders Substrates: Iron, folate, vitamin B12 Red cell mass
More informationHassan Eliwan. MBBch, MRCP, MRCPCH (UK)
MBBch, MRCP, MRCPCH (UK) 1 Personal details Name Home Address: Work Address: E mail: Hassan Omran Eliwan. 65 Crescent Building, Park West Pointe, Park West, Ireland Our Lady s Children Hospital Crumlin
More informationNEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016
NEW YORK STATE CYTOHEMATOLOGY PROFICIENCY TEST PROGRAM Glass Slide - November 2016 Results from this proficiency test event are available at: http://www.wadsworth.org/regulatory/clep/pt/summaries SLIDE
More informationFBC CASES Vernon Louw Clinical Haematology 2010
FBC CASES Vernon Louw Clinical Haematology 2010 FOR EACH OF THE FOLLOWING PATIENTS, SELECT THE MOST LIKELY FINDING FROM THE ANALYSIS OF THE PERIPHERAL BLOOD. A patient with infectious mononucleosis. A
More informationHematology Unit Lab 2 Review Material
Objectives Hematology Unit Lab 2 Review Material - 2018 Laboratory Instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided
More informationBlood Cell Identification Graded
BCP-21 Blood Cell Identification Graded Case History The patient is a 37-year-old female with a history of multiple sickle cell crises. She now presents with avascular necrosis of the left hip. Laboratory
More informationSWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL LEUKEMIA FORMS CHAPTER 16A REVISED: DECEMBER 2017
LEUKEMIA FORMS The guidelines and figures below are specific to Leukemia studies. The information in this manual does NOT represent a complete set of required forms for any leukemia study. Please refer
More informationBUSINESS PLAN Association name: Association of Sickle Cell sufferers of Yorkshire for Africa and Basic Information or ASYABI
C/O Retas The Roundhay Road Resource Centre 233-237 Roundhay Road Harehills Leeds, LS8 4HS Tel.: 07856978722 Email.:sicklecellyorkshireasyabi@yahoo.fr Website: www.asyabi.co.uk Registered Charity Number
More informationAIMS FELLOWSHIP CURRICULUM HAEMATOLOGY III
AIMS FELLOWSHIP CURRICULUM HAEMATOLOGY III Module Title: Module Code: Module Convenor: Discipline Committee: Advanced Cellular Haematology HAEM III Haematology Department St Vincent's Hospital Darlinghurst
More informationEvaluation of UK NEQAS (H) Hb A 2 and related performance data
Evaluation of UK NEQAS (H) Hb A 2 and related performance data Hannah Batterbee 1, Barbara De la Salle 2, Paul McTaggart 2, Caroline Doré 3, Barbara Wild 4 and Keith Hyde 2 1 Haematology Department, Royal
More informationDrop of Blood Unravels Mysteries. Prof. Salma Afrose Department of Hematology Dhaka Medical College
Drop of Blood Unravels Mysteries Prof. Salma Afrose Department of Hematology Dhaka Medical College Peripheral Blood Film (PBF) PBF is a laboratory workup that involves cytology of Peripheral blood cell
More informationSymptoms and Signs in Hematology/ 2013
Symptoms and Signs in Hematology/ 2013 Abdallah Abbadi.MD.FRCP Professor of Hematology & Oncology University of Jordan & JUH Email: abdalla.awidi@gmail.com Diseases of Blood & Blood forming organs A- Benign
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT DATE OF MEETING: 20th September 2012 TITLE OF REPORT: KEY MESSAGES: NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of its six strategic clinical
More informationHaematologist-reviewed peripheral blood smear in paediatric practice
Singapore Med J 2018; 59(2): 64-68 https://doi.org/10.11622/smedj.2018013 Haematologist-ed peripheral blood smear in paediatric practice Anselm Chi-wai Lee, MBBS, FAMS ABSTRACT Manual examination of the
More informationThe patient had a mild splenomegaly but no obvious lymph node enlargement. The consensus phenotype obtained from part one of the exercise was:
Case History An 86 year old male was admitted to hospital with chest infection. Haematological examination subsequently revealed the following: Hb- 11.0 g/dl; WBC- 67.1 x 10^9/l; PLT- 99 x10^9/l; RBC-
More informationOur Summary Annual Report and Quality Account for 2015/16. gmw.nhs.uk
Our Summary Annual Report and Quality Account for 2015/16 gmw.nhs.uk Reporting back, Looking Forward 3 Reporting Back 2015/16 has continued to see significant challenge facing the NHS nationally, and
More informationArts Award Shared Offer Project
Creative Projects at Roundhouse, 2014. Photo: Ali Painter Arts Award Shared Offer Project Introduction In our roles as Arts Council England Associate Bridge Organisations for London, Roundhouse and Sadler
More informationMorphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital
Morphology Case Study Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital 41 year old male presented to GP for routine check-up in May 2011. FBC Results:
More informationDraft Falls Prevention Strategy
Cheshire West & Chester Council Draft Falls Prevention Strategy 2017-2020 Visit: cheshirewestandchester.gov.uk Visit: cheshirewestandchester.gov.uk 02 Cheshire West and Chester Council Draft Falls Prevention
More informationHaematology and Haematological Oncology
Haematology and Haematological Oncology Updated on 23 Feb 2017 I) OBJECTIVES 1. To provide a broad training and in-depth experience at a level sufficient for trainees to acquire competence and professionalism
More information10:00 Chair s welcome and opening remarks Richard Caulfield, Regional Director, Association of Colleges
Programme 09:15 Registration and refreshments 10:00 Chair s welcome and opening remarks 10:15 Transforming children and young people s mental health provision Barbara Rayment, Head of Policy, Children
More informationInventory Practice Survey 2008 Report - Headline summary
Inventory Practice Survey 2008 Report - Headline summary Making the most of the BSMS 64% of hospitals use senior BMS to enter data Almost 80 enter stock data at least on a weekly basis Nearly a third of
More informationClinical Guidelines for Leukaemia and other Myeloid Disorders MDS
Clinical Guidelines for Leukaemia and other Myeloid Disorders MDS Reference Number Version Status Executive Lead(s) Name and Job Title Author(s) Name and Job Title 13-2H-106 2 Dr Helen Barker MDT Lead
More informationSouth East Dermatology Transformation and Sustainability Network Thursday 19 th April 2018 Holiday Inn Guildford
South East Dermatology Transformation and Sustainability Network Thursday 19 th April 2018 Holiday Inn Guildford The regional Transformation and Sustainability Network meetings are initiated and organised
More informationTherapeutic Apheresis Services Annual Review 2016/17
Therapeutic Apheresis Services Annual Review 2016/17 NHS Blood and Transplant (NHSBT) is a major provider of Therapeutic Apheresis Services (TAS) in the NHS. Services are provided across England. Collection
More informationCPD profile. 1.1 Full name: Clinical Biochemist 1.2 Profession: Clinical scientist 1.3 Registration number: CSXXXX. 2. Summary of recent work/practice
CPD profile 1.1 Full name: Clinical Biochemist 1.2 Profession: Clinical scientist 1.3 Registration number: CSXXXX 2. Summary of recent work/practice The Trust I work at consists of two hospitals. As a
More informationR e s e a r c h S t r a t e g y
Sheffield Teaching Hospitals NHS Foundation Trust Academic Directorate of Specialised Cancer R e s e a r c h S t r a t e g y Academic Directorate of Specialised Cancer Research Strategy Executive Summary
More informationBorderline cytopenias. Dr Taku Sugai Consultant Haematologist
Borderline cytopenias Dr Taku Sugai Consultant Haematologist Borderline cytopenias Neutropenia Thrombocytopenia Anaemia with normal haematinics Two recent cases of cytopenias Neutropenia ANC of more than
More informationMDS: Who gets it and how is it diagnosed?
MDS: Who gets it and how is it diagnosed? October 16, 2010 Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine Weill Medical College of Cornell University The New York Presbyterian
More informationMyeloproliferative Disorders - D Savage - 9 Jan 2002
Disease Usual phenotype acute leukemia precursor chronic leukemia low grade lymphoma myeloma differentiated Total WBC > 60 leukemoid reaction acute leukemia Blast Pro Myel Meta Band Seg Lymph 0 0 0 2
More informationTPS Connects. Conference 2011
TPS Connects Conference 011 Bringing everyone together Turning Point Scotland s strap line states that it provides person centred support to adults with a range of complex needs. But how do we make person-centred
More informationGenetics of Thalassemia
Genetics of Thalassemia Submitted by : Raya Samir Al- Hayaly Sura Zuhair Salih Saad Ghassan Al- Dulaimy Saad Farouq Kassir Sama Naal Salouha Zahraa Jasim Al- Aarajy Supervised by : Dr. Kawkab Adris Mahmod
More informationMadLab // Annual Survey, Postcode Survey, & Community Group Audit
MadLab // Annual Survey, Postcode Survey, & Community Group Audit - 2017 MadLab makes the impossible seem possible. Methodology // In January 2017, MadLab conducted three surveys: - Annual Survey 291 responses
More information2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228
2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 Vishnu V. B Reddy, MD University of Alabama at Birmingham Birmingham, AL USA 11/03/07
More informationKathleen Finnegan MS MT(ASCP)SHCM
Kathleen Finnegan MS MT(ASCP)SHCM Discuss the history of hematology automation and digital differentials. Discuss the HemoFAXS Hematology Analysis System by Tissue Gnostics. Review automated microscopy
More informationCurriculum Vitae. Dr. Shruthi Narayan. MBBS, MD (Paediatrics), MRCPCH (UK), FRCPath (Haematology), MSc (Leadership and Service Improvement)
Curriculum Vitae Dr. Shruthi Narayan MBBS, MD (Paediatrics), MRCPCH (UK), FRCPath (Haematology), MSc (Leadership and Service Improvement) SN 1/6 Personal Particulars Name Contact Address Telephone Number
More informationHEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY
HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEMATOCRIT Hematocrit is a measure of the percentage of the total blood volume that is made up by the red blood cells The hematocrit can be determined directly
More informationClinical Guidelines for Leukaemia and other Myeloid Disorders MDS
Clinical Guidelines for Leukaemia and other Myeloid Disorders MDS Reference Number Version Status Executive Lead(s) Name and Job Title Author(s) Name and Job Title 13-2H-106 1 Dr Helen Barker MDT Lead
More informationCONNECTED COUNSELLING Digital mental health and well-being services working with the offline world
CONNECTED COUNSELLING Digital mental health and well-being services working with the offline world Last year and this year I suffered with depression and anger issues so I started using Kooth. Since then
More informationDisclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms
Myeloproliferative Neoplasms: A Case-Based Approach Disclosures No conflicts of interests regarding the topic being presented Adam M. Miller, MD PGY-4 Resident Physician Department of Pathology and Laboratory
More informationAcademic Clinical Fellowship in Geriatric Medicine
Academic Clinical Fellowship in Geriatric Medicine Description of ACF Programme: Title: Geriatric Medicine Duration: 3 years Lead NHS Hospital/Trust and contact details: University Hospital Southampton
More informationNHSBT Board September Chief Executive s Board Report
16-77 NHSBT Board September 29 2016 Chief Executive s Board Report 1. Status Public 2. Executive Summary This paper summarises key communications activity and highlights other issues of performance and
More informationCase Study: Biomedical Scientist - Caroline
Case Study: Biomedical Scientist - Caroline What do you do? I'm a biomedical scientist, in haematology. I work in an NHS hospital. We study the morphology of the cells - what they actually look like, such
More informationThe LaboratoryMatters
Laboratory Medicine Newsletter for clinicians, pathologists & clinical laboratory technologists. A Initiative. Complete Blood Count This issue highlights: CBC, while ubiquitous, is an excellent diagnostic
More informationPolicy: Client Involvement and Empowerment
Policy: Client Involvement and Empowerment Updated January 2017 Contents: 1. Introduction 2. How do we involve and empower those to whom we provide housing and/or support? 3. How do we involve and empower
More informationXN series. Case interpretation. Gebruikersdag Vlaanderen- 6 oktober 2016
XN series Case interpretation Gebruikersdag Vlaanderen- 6 oktober 2016 Fluorescence flow cytometry RET channel PLT-F channel WDF channel WPC channel WNR channel Case 1 Case 1: Initial measurement Patient
More informationPatients as consumers of healthcare: the role of innovation in self-care and self-management
Engineering Innovation in the NHS Royal Academy of Engineering Conference Patients as consumers of healthcare: the role of innovation in self-care and self-management Prof. Lionel Tarassenko FREng Institute
More informationMyeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP
Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS
More informationHematology Unit Lab 1 Review Material
Hematology Unit Lab 1 Review Material - 2018 Objectives Laboratory instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided
More informationAbout Mental Health First Aid
About Mental Health First Aid Mental Health First Aid (MHFA) courses, first developed in Australia in 2001, provide robust evidence-based training that increase mental health literacy and help turn awareness
More information10:00 Chair s welcome and opening remarks Richard Caulfield, Regional Director, Association of Colleges
Programme 09:15 Registration and refreshments 10:00 Chair s welcome and opening remarks 10:15 Transforming children and young people s mental health provision Barbara Rayment, Head of Policy, Children
More informationMECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008
MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA April 16, 2008 FACULTY COPY GOAL: Learn the appearance of normal peripheral blood elements and lymph nodes. Recognize abnormal peripheral blood
More informationOrdering Physician CLIENT,CLIENT. Collected REVISED REPORT
HPWET Hematopathology Consultation, MML Embed Client Hematopathology Consult REVISED INAL DIAGNOSIS Interpretation Peripheral blood, bone marrow aspirate and biopsies, bilateral iliac crests: 1. Normocellular
More informationSystemic Therapy Re-Imagined: A series of CPD workshops for health and social care professionals (CPD73)
Systemic Therapy Re-Imagined: A series of CPD workshops for health and social care professionals (CPD73) Trust Certificate May - November 2015 Course Type On site Course Length 3 sessions Study Attendance
More informationScottish Clinical Leadership Fellowship About the SCLF
Scottish Clinical Leadership Fellowship About the SCLF Scottish Clinical Leadership Fellowship This guide introduces the Scottish Clinical Leadership Fellowship (SCLF) for doctors and dentists in training,
More informationLondon Cancer. Myelofibrosis guidelines. August Review August Version v1.0. Page 1 of 12
London Cancer Myelofibrosis guidelines August 2013 Review August 2013 Version v1.0 Page 1 of 12 CONTENTS 1. DIAGNOSIS... 3 1a. BCSH (2012)... 3 1b. WHO (2009) diagnostic criteria for PMF:... 4 2. MOLECULAR
More informationCase scenarios: Patient Group Directions
Putting NICE guidance into practice Case scenarios: Patient Group Directions Implementing the NICE guidance on Patient Group Directions (MPG2) Published: March 2014 [updated March 2017] These case scenarios
More informationDialogue between Clinician and Pathologist on CBC report
Dialogue between Clinician and Pathologist on CBC report Dr. Seema Bhatwadekar Haematologist, Oncohaematologist & Transplant Physician Vadodara. CBC PBS Most important test to make probable diagnosis Crucial
More informationNES/15/100. This update paper highlights the main areas of work within the Directorate and shows the direction of travel.
NES Item 8c December 2015 NES/15/100 (Enclosure) NHS Education for Scotland Board Paper Summary 1. Title of Paper Optometry within NES Developing Primary Eyecare 2. Author(s) of Paper Dr Janet Pooley,
More informationSPECIALIST REGISTRAR PAEDIATRIC HISTOPATHOLOGY JOB DESCRIPTION. Page 1 of 10
SPECIALIST REGISTRAR IN PAEDIATRIC HISTOPATHOLOGY JOB DESCRIPTION SEPTEMBER 2011 Page 1 of 10 THE CENTRAL MANCHESTER UNIVERSITY NHS FOUNDATION TRUST - ROYAL MANCHESTER CHILDREN S HOSPITAL DEPARTMENT OF
More informationHematology 101. Cindy Rogers, MT(ASCP) Diagnostics System Specialist
Hematology 101 Cindy Rogers, MT(ASCP) Diagnostics System Specialist More Acronyms...» CBC» RBC» HGB» HCT» WBC» MPV» PLT» RDW» DIFF» H&H» Complete Blood Count» Red Blood Cell» Hemoglobin» Hematocrit» White
More informationMORPHOLOGY OF BONE MARROW ASPIRATES. Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman
MORPHOLOGY OF BONE MARROW ASPIRATES Dr.Prasanna N Kumar Head Department of Pathology, Oman Medical College, Oman BONE MARROW ASPIRATION Sites Sternum Anterior or posterior iliac spines Aspiration from
More informationSTRATEGIC PLAN
STRATEGIC PLAN 2016 2020 Promoting and supporting excellence in research www.immunology.org BSI STRATEGY 2016 2020 EXECUTIVE SUMMARY OUR MISSION Our mission is to promote excellence in immunological research,
More informationUK NEQAS Low Level Leucocyte Enumeration Programme. Mr Matthew Fletcher Advanced Biomedical Scientist UK NEQAS for Leucocyte Immunophenotyping
UK NEQAS Low Level Leucocyte Enumeration Programme Mr Matthew Fletcher Advanced Biomedical Scientist UK NEQAS for Leucocyte Immunophenotyping Content Results of the UKNEQASLI flow cytometry survey Analysis
More informationThe Stolen Years Mental Health and Smoking Action Report 22 April Emily James, Policy and Campaigns Officer
The Stolen Years Mental Health and Smoking Action Report 22 April 2016 Emily James, Policy and Campaigns Officer Emily.James@ash.org.uk Where we are now? Overview The Stolen Years: Mental Health and Action
More information